Correlation Between Anika Therapeutics and Paragon 28

Can any of the company-specific risk be diversified away by investing in both Anika Therapeutics and Paragon 28 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anika Therapeutics and Paragon 28 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anika Therapeutics and Paragon 28, you can compare the effects of market volatilities on Anika Therapeutics and Paragon 28 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anika Therapeutics with a short position of Paragon 28. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anika Therapeutics and Paragon 28.

Diversification Opportunities for Anika Therapeutics and Paragon 28

0.26

Correlation Coefficient

Anika Therapeutics  Paragon 28

Modest diversification

The 3 months correlation between Anika and Paragon is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and Paragon 28 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paragon 28 and Anika Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anika Therapeutics are associated (or correlated) with Paragon 28. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paragon 28 has no effect on the direction of Anika Therapeutics i.e., Anika Therapeutics and Paragon 28 go up and down completely randomly.

Pair Corralation between Anika Therapeutics and Paragon 28

Given the investment horizon of 90 days Anika Therapeutics is expected to generate 4.28 times less return on investment than Paragon 28. But when comparing it to its historical volatility, Anika Therapeutics is 1.43 times less risky than Paragon 28. It trades about 0.06 of its potential returns per unit of risk. Paragon 28 is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  1,050  in Paragon 28 on November 19, 2024 and sell it today you would earn a total of  256.00  from holding Paragon 28 or generate 24.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Anika Therapeutics  vs.  Paragon 28

Anika Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Anika Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent forward indicators, Anika Therapeutics is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Paragon 28

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Paragon 28 are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile basic indicators, Paragon 28 sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Anika Therapeutics and Paragon 28

The main advantage of trading using opposite Anika Therapeutics and Paragon 28 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anika Therapeutics position performs unexpectedly, Paragon 28 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paragon 28 will offset losses from the drop in Paragon 28's long position.

The idea behind Anika Therapeutics and Paragon 28 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.